TET2 and atrial fibrillation: The findings revealed that CHIP mutations were significantly more prevalent in AF patients (23.6%) than in controls (10.7%), with adjusted odds ratios (OR) of 1.38 for all CHIP mutations and 1.65 for TET2 mutations [40].